Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINE1 | P05121 | 8/20 | 0.44 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | XDH | P47989 | 1/20 | 0.37 |
| ▸ | GFER | P55789 | 1/20 | 0.37 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.37 |
| ▸ | RELA | Q04206 | 1/20 | 0.37 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 2/20 | 0.35 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.33 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.33 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15142163 | 1.00 | SERPINE1 (0.44) | SERPINE1PTPN2PTPN1PTPN11POLB | |
| SCHEMBL28446906 | 1.00 | SERPINE1 (0.44) | SERPINE1PTPN2PTPN1PTPN11POLB | |
| SCHEMBL28447050 | 0.91 | SERPINE1 (0.46) | SERPINE1PTPN2PTPN1PTPN11POLB | |
| SCHEMBL1137255 | 0.91 | SERPINE1 (0.46) | SERPINE1PTPN2PTPN1PTPN11POLB | |
| SCHEMBL20578325 | 0.89 | SERPINE1 (0.47) | SERPINE1PTPN2PTPN1PTPN11POLB | |
| SCHEMBL31485713 | 0.89 | SERPINE1 (0.47) | SERPINE1PTPN2PTPN1PTPN11POLB | |
| SCHEMBL1159921 | 0.89 | SERPINE1 (0.47) | SERPINE1PTPN2PTPN1PTPN11POLB | |
| Gallic Acid SCHEMBL10712693 | 0.88 | POLB (0.36) | SERPINE1PTPN2PTPN1PTPN11POLB | |
| SCHEMBL17156389 | 0.88 | SERPINE1 (0.46) | SERPINE1PTPN2PTPN1PTPN11POLB | |
| SCHEMBL28178896 | 0.88 | SERPINE1 (0.46) | SERPINE1PTPN2PTPN1PTPN11POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111624269-A | Method for screening drug effect substances for treating adenomyosis in cassia twig and poria cocos pills | 山东中医药大学附属医院 | 2020-09-04 | — | — | CN | claimed |
| US-20190390090-A1 | ADHESIVE FOR PELLICLE, PELLICLE FOR PHOTO MASK AND METHOD FOR MANUFACTURING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-12-26 | — | — | US | claimed |
| CN-102772499-B | Effective parts obtained by alcohol extraction of raw materials of Relingqing granules as well as preparation method and applications thereof | GUIZHOU WARMEN PHARMACEUTICAL CO LTD | 2014-01-08 | — | — | CN | claimed |
| CN-102772499-A | Effective parts obtained by alcohol extraction of raw materials of Relingqing granules as well as preparation method and applications thereof | GUIZHOU WARMEN PHARMACEUTICAL CO LTD | 2012-11-14 | — | — | CN | claimed |
| EP-1545554-A4 | METHODS AND COMPOSITIONS FOR TREATING DIABETES MELLITIS | UNIV OHIO (US) | 2006-06-14 | — | — | EP | claimed |
| US-20060058243-A1 | Methods and compositions for treating diabetes mellitis | OHIO UNIVERSITY | 2006-03-16 | — | — | US | claimed |
| EP-1545554-A1 | METHODS AND COMPOSITIONS FOR TREATING DIABETES MELLITIS | Ohio University (US) | 2005-06-29 | — | — | EP | claimed |
| WO-2004009094-A1 | METHODS AND COMPOSITIONS FOR TREATING DIABETES MELLITIS | OHIO UNIVERSITY (US) | 2004-01-29 | — | — | WO | claimed |
| US-12258494-B2 | Adhesive for pellicle, pellicle for photo mask and method for manufacturing the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-03-25 | — | — | US | disclosed |
| CN-118203695-A | Sprayable hydrogel and preparation method and application thereof | 石河子大学 | 2024-06-18 | — | — | CN | disclosed |
| CN-112375803-B | Screening method of anti-inflammatory active component ethyl gallate in gallnut and application thereof | 石河子大学 | 2024-05-07 | — | — | CN | disclosed |
| US-20240091170-A1 | Catechol Nanoparticle, Catechol Protein Nanoparticle, and Preparation Method and Use Thereof | SHIHEZI UNIVERSITY (CN) | 2024-03-21 | — | — | US | disclosed |
| US-20230399552-A1 | ADHESIVE FOR PELLICLE, PELLICLE FOR PHOTO MASK AND METHOD FOR MANUFACTURING THE SAME | SAMSUNG ELECTRONICS CO LTD (KR) | 2023-12-14 | — | — | US | disclosed |
| CN-115300496-B | Catechol nanoparticle, catechol protein nanoparticle, and preparation methods and applications thereof | 石河子大学 | 2023-09-26 | — | — | CN | disclosed |
| US-20130004936-A1 | SUPERCOOLING PROMOTING AGENT | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSIT (JP) | 2013-01-03 | — | — | US | disclosed |
| CN-102772499-A | Effective parts obtained by alcohol extraction of raw materials of Relingqing granules as well as preparation method and applications thereof | GUIZHOU WARMEN PHARMACEUTICAL CO LTD | 2012-11-14 | — | — | CN | disclosed |
| EP-1545554-A4 | METHODS AND COMPOSITIONS FOR TREATING DIABETES MELLITIS | UNIV OHIO (US) | 2006-06-14 | — | — | EP | disclosed |
| US-20060058243-A1 | Methods and compositions for treating diabetes mellitis | OHIO UNIVERSITY | 2006-03-16 | — | — | US | disclosed |
| EP-1545554-A1 | METHODS AND COMPOSITIONS FOR TREATING DIABETES MELLITIS | Ohio University (US) | 2005-06-29 | — | — | EP | disclosed |
| WO-2004009094-A1 | METHODS AND COMPOSITIONS FOR TREATING DIABETES MELLITIS | OHIO UNIVERSITY (US) | 2004-01-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060058243-A1 | Methods and compositions for treating diabetes mellitis | IAPP, GCG, MTPN | SERPINE1 196/4885PTPN2 2187/4885PTPN1 1169/4885 |
| US-20130004936-A1 | SUPERCOOLING PROMOTING AGENT | TREH, HYOU1, UGGT1 | SERPINE1 734/4885PTPN2 4029/4885PTPN1 3578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.